Protein aggregation as bacterial inclusion bodies is reversible
- PMID: 11231008
- DOI: 10.1016/s0014-5793(01)02073-7
Protein aggregation as bacterial inclusion bodies is reversible
Abstract
Inclusion bodies are refractile, intracellular protein aggregates usually observed in bacteria upon targeted gene overexpression. Since their occurrence has a major economical impact in protein production bio-processes, in vitro refolding strategies are under continuous exploration. In this work, we prove spontaneous in vivo release of both beta-galactosidase and P22 tailspike polypeptides from inclusion bodies resulting in their almost complete disintegration and in the concomitant appearance of soluble, properly folded native proteins with full biological activity. Since, in particular, the tailspike protein exhibits an unusually slow and complex folding pathway involving deep interdigitation of beta-sheet structures, its in vivo refolding indicates that bacterial inclusion body proteins are not collapsed into an irreversible unfolded state. Then, inclusion bodies can be observed as transient deposits of folding-prone polypeptides, resulting from an unbalanced equilibrium between in vivo protein precipitation and refolding that can be actively displaced by arresting protein synthesis. The observation that the formation of big inclusion bodies is reversible in vivo can be also relevant in the context of amyloid diseases, in which deposition of important amounts of aggregated protein initiates the pathogenic process.
Similar articles
-
Amyloid-like properties of bacterial inclusion bodies.J Mol Biol. 2005 Apr 15;347(5):1025-37. doi: 10.1016/j.jmb.2005.02.030. J Mol Biol. 2005. PMID: 15784261
-
Localization of functional polypeptides in bacterial inclusion bodies.Appl Environ Microbiol. 2007 Jan;73(1):289-94. doi: 10.1128/AEM.01952-06. Epub 2006 Nov 3. Appl Environ Microbiol. 2007. PMID: 17085715 Free PMC article.
-
Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.J Biotechnol. 2007 Jan 1;127(2):244-57. doi: 10.1016/j.jbiotec.2006.07.004. Epub 2006 Jul 16. J Biotechnol. 2007. PMID: 16945443
-
Concepts and tools to exploit the potential of bacterial inclusion bodies in protein science and biotechnology.FEBS J. 2011 Jul;278(14):2408-18. doi: 10.1111/j.1742-4658.2011.08163.x. Epub 2011 May 31. FEBS J. 2011. PMID: 21569207 Review.
-
Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.Biopolymers. 1999;51(4):297-307. doi: 10.1002/(SICI)1097-0282(1999)51:4<297::AID-BIP5>3.0.CO;2-I. Biopolymers. 1999. PMID: 10618597 Review.
Cited by
-
Transient sampling of aggregation-prone conformations causes pathogenic instability of a parkinsonian mutant of DJ-1 at physiological temperature.Protein Sci. 2015 Oct;24(10):1671-85. doi: 10.1002/pro.2762. Epub 2015 Aug 17. Protein Sci. 2015. PMID: 26234586 Free PMC article.
-
A novel fed-batch based cultivation method provides high cell-density and improves yield of soluble recombinant proteins in shaken cultures.Microb Cell Fact. 2010 Feb 19;9:11. doi: 10.1186/1475-2859-9-11. Microb Cell Fact. 2010. PMID: 20167131 Free PMC article.
-
Heterologous expression of plasmodial proteins for structural studies and functional annotation.Malar J. 2008 Oct 1;7:197. doi: 10.1186/1475-2875-7-197. Malar J. 2008. PMID: 18828893 Free PMC article. Review.
-
Recombinant protein expression in Escherichia coli: advances and challenges.Front Microbiol. 2014 Apr 17;5:172. doi: 10.3389/fmicb.2014.00172. eCollection 2014. Front Microbiol. 2014. PMID: 24860555 Free PMC article. Review.
-
A step ahead: combining protein purification and correct folding selection.Microb Cell Fact. 2004 Oct 7;3(1):12. doi: 10.1186/1475-2859-3-12. Microb Cell Fact. 2004. PMID: 15471550 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources